Canada· CA-DIN-02389169
KOMBOGLYZE
A metformin and saxagliptin product containing saxagliptin (saxagliptin hydrochloride) + metformin hydrochloride, registered in Canada by ASTRAZENECA CANADA INC. The same ATC class is registered in 12 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Metformin and saxagliptin is registered in 12 of 19 countries.
Countries holding a registration under ATC A10BD10 (metformin and saxagliptin), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Metformin and saxagliptin · ATC A10BD10
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE) + METFORMIN HYDROCHLORIDE
- Manufacturer
- ASTRAZENECA CANADA INC
- Country
- Canada (CA)
- ATC code
- A10BD10
- ATC class
- Metformin and saxagliptin
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for metformin and saxagliptin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metformin and saxagliptin · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Metformin and saxagliptin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaKOMBOGLYZEAstraZeneca AB, Södertälje
- United StatesSaxagliptin and MetforminMylan Pharmaceuticals Inc.
- SwitzerlandKombiglyze XR
- United KingdomKomboglyze 2.5mg/1000mg tabletsDE Pharmaceuticals
- SpainKOMBOGLYZE 2,5 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAstrazeneca Ab
- FinlandKomboglyzeAstraZeneca AB
- IrelandKomboglyze 2.5 mg/1000 mg film-coated tabletsAstraZeneca AB
- IcelandKomboglyzeAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- France · Saxagliptine/Metformine Biogaran
- Iceland · Komboglyze
- Liechtenstein · Komboglyze
- Malta · Saxagliptin/Metformin Pharos
- Norway · Komboglyze
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5e35f7f4-58f5-491c-ae18-435d317ce87f GET /v1/drugs/5e35f7f4-58f5-491c-ae18-435d317ce87f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02389169",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "A10BD10",
"schedule": [
"Prescription"
],
"drug_code": "87467",
"strengths": [
"2.5 MG",
"500 MG"
],
"ahfs_class": null,
"substances": [
"SAXAGLIPTIN (SAXAGLIPTIN HYDROCHLORIDE)",
"METFORMIN HYDROCHLORIDE"
],
"product_categorization": null
}See everything about metformin and saxagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.